<p>In this paper, we present a predictive model based on artificial neural network (ANN) to evaluate principal physicochemical properties of a set of anti-inflammatory drugs based on chosen topological indices. The molecular descriptors were calculated from molecular structures and employed as the inputs to the ANN model. Normalization of the feature set was carried out before training to maintain convergence and stability of the model. The ANN exhibited excellent predictive ability based on a <InlineEquation ID="IEq1"> <InlineMediaObject> <ImageObject Color="BlackWhite" FileRef="41598_2025_9878_Article_IEq1.gif" Format="GIF" Height="16" Rendition="HTML" Resolution="72" Type="Linedraw" Width="21" /> </InlineMediaObject> <EquationSource Format="TEX">\(R^2\)</EquationSource> </InlineEquation> value of 0.94 and a mean squared error (MSE) of 0.0087 on the test set. The chemical structure data used were mainly retrieved from ChemSpider. The method showcases the promise of machine learning models to facilitate better virtual screening and assist in rational drug design by making accurate predictions of properties.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Advanced QSPR modeling of profens using machine learning and molecular descriptors for NSAID analysis

  • W. Eltayeb Ahmed,
  • Muhammad Farhan Hanif,
  • Muhammad Kamran Siddiqui,
  • Brima Gegbe

摘要

In this paper, we present a predictive model based on artificial neural network (ANN) to evaluate principal physicochemical properties of a set of anti-inflammatory drugs based on chosen topological indices. The molecular descriptors were calculated from molecular structures and employed as the inputs to the ANN model. Normalization of the feature set was carried out before training to maintain convergence and stability of the model. The ANN exhibited excellent predictive ability based on a \(R^2\) value of 0.94 and a mean squared error (MSE) of 0.0087 on the test set. The chemical structure data used were mainly retrieved from ChemSpider. The method showcases the promise of machine learning models to facilitate better virtual screening and assist in rational drug design by making accurate predictions of properties.